Table 4.
Comparison of urinary SARS-CoV-2 nucleic acid detection in literature reports.
| Authors | Sampling Method | Detecting Method | Positive Rate | Target Gene | Detection Kit | Participants Condition | Refs. |
|---|---|---|---|---|---|---|---|
| Huiming Wang, et al. | Urine sediments | RT-PCR | 28.3% | NP and ORF1ab | Zhongzhi, Wuhan | 30 non-severe 23 severe |
This article |
| Luwen Wang, et al. | Urine sediments | RT-PCR | 7.5% | NP and ORF1ab | Zhongzhi, Wuhan | 48 non-CKD, 5 CKD | [11] |
| Chaolin Huang, et al. | Urine | RT-PCR | 11% | NP and ORF1ab | ND | 9 moderates | [2] |
| Hongzhou Lu, et al. | Urine | RT-PCR | 6.9% | NP and ORF1ab | Master Biotechnology, China | Recovered | [7] |
| Zhenglin Yang, et al. | Urine | RT-PCR | 0% | NP and ORF1ab | GeneoDx (GZ-TRM2, China), Maccura (Sichuan, China) and Liferiver (W-RR-0479-02, China) | 5 Uncomplicated, 14 complicated | [9] |
| Barnaby Edward Young, et al | Urine | RT-PCR | 0% | N, S, and ORF1ab | EZ1 virus mini kit v2.0 (Qiagen) |
6 mild, 4 severe | [10] |
| Roman Wölfel, et al. | Urine | RT-PCR | 0% | E- and RdRp | Tib-Molbiol, Berlin, Germany | mild | [12] |
| Chin Ion Lei, et al. | Urine | qRT-PCR | 0% | NP and ORF1ab | BioGerm, China | 2 mild, 4 moderates | [12] |
| Fujie Zhang, et al. | Urine | RT-PCR and ddPCR | 0% | NP and ORF1ab | Shanghai BioGerm Medical Technology Co. LTD, China (RT-PCR) TargetingOne, Beijing, China (ddPCR) |
ND | [13] |
ND: not determined. Detecting Method: reverse transcription-polymerase chain reaction (RT-PCR); Positive Rate: positive rate of urinary SARS-CoV-2 RNA; Target Gene: Targeting SARS-CoV-2 genes.